Does Canagliflozin And Metformin Hydrochloride Interact with Ritonavir?
CDI records a moderate classification for Canagliflozin And Metformin Hydrochloride and Ritonavir. The stored summary is: UGT enzyme inducer that decreases canagliflozin exposure and may reduce effectiveness. May require canagliflozin dose increase. The mechanism involves ugt enzyme induction decreases canagliflozin exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Ritonavir Class
- Cytochrome P450 3A Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
UGT enzyme induction decreases canagliflozin exposure
What To Tell Your Doctor or Pharmacist
If you are taking Canagliflozin And Metformin Hydrochloride and your doctor is considering prescribing Ritonavir (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider